Capital Markets - France | Fieldfisher
Skip to main content
Select location France
  • Services
  • Capital Markets

Capital Markets

Fieldfisher France's Capital Markets department has extensive experience in market transactions.

A complex financial chart displays various fluctuating stock prices and trading volumes in blue, green, red, and purple lines and bars. Multiple overlays of line graphs and bar charts represent different market trends and data points against a dark grid background.

Why choose our Capital Markets lawyers?

The team advises companies from various sectors, such as life sciences (biotech and medtech), new technologies, cleantech or aeronautics. It also assists investment services providers and investment funds. Our range of expertise means clients can instruct us on any issue with confidence.

Close-up image of a financial graph with candlestick chart patterns reflecting stock market data. The background is dark with a neon pink, blue, and purple glow, creating a futuristic and dynamic visual effect.

The team assists clients with:         

  • Initial public offerings:   The regulated market of Euronext Paris, Euronext Growth or Euronext Access: structuring the transaction, corporate documentation, drafting of the prospectus, instruction to the AMF  
  • Securities offerings:   Capital increases, debt securities issues, structured product issues (e.g. OCA, OCEANE, ORNANE), operations combining fundraising and management incentives (e.g. OBSAAR)   
  • Takeover bids:   Solicited or unsolicited takeover bids (offer, exchange, withdrawal), public repurchase bids, delisting, takeover strategies (concerted action), anti-takeover defense  
  • Merger and acquisition transactions  involving listed companies   
  • Assistance to listed companies and their managers on a daily basis: Board meetings, annual shareholders' meetings, annual and bi-annual reports, universal registration documents, reporting obligations, prevention of market abuse
  • Investment in listed companies: Crossing thresholds and declarations of intent, control issues, other reporting obligations, prevention of market abuse
  •  Governance:  Governance charters, best practices, directors' liability
  • Stock exchange litigation: Litigation of takeover bids, assistance to issuers, their managers or shareholders in the context of AMF investigation procedures (e.g. repression of market abuse) 
  • Listed companies employee ownership: Employee profit-sharing schemes such as employee savings plans, stock option plans, free share grants or free preference shares



Recent Deals

  • Advising Oddo BHF and Natixis in their capacity as global coordinators, joint lead managers and bookrunners on Arcure's IPO on Euronext Growth Paris (€7,9M)
  • Acting as deal counsel on VOGO's IPO on Euronext Growth Paris by way of a capital increase (€14,2M)
  • Acting as deal counsel on BIO-UV Group's IPO by way of a capital increase on Euronext Growth Paris (€10M)Advising CM-CIC Market Solutions and Natixis in their capacity as global coordinators, joint lead managers and bookrunners for the share capital increase of GL Events, a leading events company listed on the regulated market of Euronext Paris (€107M)
  • Acting as deal counsel in Carbios' capital increase by accelerated book building. Copernicus AM, Michelin Venture, L’Oréal via its capital-investment fund BOLD (Business Opportunities for L'Oréal Development) and Truffle Capital have subscribed to the capital increase (€14,5M) 
  • Acting as deal counsel on AwoX's dual share capital increase with preferential subscription rights and on an issue of bonds convertible into and/or exchangeable for new or existing shares (€7,5M)
  • Advising DEINOVE on the contribution in kind allowing the company to acquire BIOVERTIS and its German subsidiary MORPHOCHEM, and on its €8.5M capital increase, performed via an accelerated book building
  • Advising Focus Home in its capital increase by way of a private placement addressed to qualified Investors through an accelerated book building process (€13M)
  • Advising BIO-UV Group on its acquisition of 100% of the shares of Triogen Holdings Limited and its subsidiary SUEZ Purification and Disinfection Systems Ltd, together "Triogen", a SUEZ Water Technologies & Solutions entity (£6,3M)

Key contact

see full team